Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Infarct Tissue Heterogeneity by Contrast-Enhanced Magnetic Resonance Imaging Is A Novel Predictor of Mortality in Patients with Chronic Coronary Artery Disease and Left Ventricular Dysfunction

Infarct Tissue Heterogeneity by Contrast-Enhanced Magnetic Resonance Imaging Is A Novel Predictor... Background—Strategies for prevention of sudden cardiac death (SCD) focus on severe left ventricular (LV) dysfunction, though most SCD post-myocardial infarction occurs in patients with mild/moderate LV dysfunction. We tested the hypothesis that infarct heterogeneity by cardiac magnetic resonance (CMR) is associated with mortality beyond left ventricular ejection fraction (LVEF) in patients with coronary artery disease (CAD) and LV dysfunction. In addition, we examined the association between infarct heterogeneity and mortality in those with LVEF>35%. Methods and Results—We studied 301 patients with CAD and LV dysfunction referred for CMR. We quantified total infarct mass, infarct core mass, and peri-infarct zone normalized for total infarct mass (%PIZ) using signal-intensity criteria of >2SDs, >3SDs, and 2-to-3SDs above remote myocardium, respectively. Mean LVEF was 41±14%. After 3.9 years median follow-up, 66 (22%) patients died (13 SCD; 33 with LVEF>35%). In patients with LVEF >35%, below- median %PIZ carried an annual death rate of 2.8% versus 12% in patients with above- median %PIZ (p<0.001). In a multivariable model, %PIZ maintained strong association with mortality adjusted to patient age, LVEF, RVEF, prolonged QT interval, and total infarct size and resulted in improve risk reclassification 0.492 [95% CI 0.183-0.817]. Conclusions—CMR infarct heterogeneity has a strong association http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Circulation: Cardiovascular Imaging Wolters Kluwer Health

Infarct Tissue Heterogeneity by Contrast-Enhanced Magnetic Resonance Imaging Is A Novel Predictor of Mortality in Patients with Chronic Coronary Artery Disease and Left Ventricular Dysfunction

Circulation: Cardiovascular Imaging , Volume Publish Ahead of Print – Oct 1, 2014

Loading next page...
 
/lp/wolters-kluwer-health/infarct-tissue-heterogeneity-by-contrast-enhanced-magnetic-resonance-0N8FvQT9Pa

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
© 2014 American Heart Association, Inc.
ISSN
1941-9651
eISSN
1942-0080
DOI
10.1161/CIRCIMAGING.113.001293
pmid
25287527
Publisher site
See Article on Publisher Site

Abstract

Background—Strategies for prevention of sudden cardiac death (SCD) focus on severe left ventricular (LV) dysfunction, though most SCD post-myocardial infarction occurs in patients with mild/moderate LV dysfunction. We tested the hypothesis that infarct heterogeneity by cardiac magnetic resonance (CMR) is associated with mortality beyond left ventricular ejection fraction (LVEF) in patients with coronary artery disease (CAD) and LV dysfunction. In addition, we examined the association between infarct heterogeneity and mortality in those with LVEF>35%. Methods and Results—We studied 301 patients with CAD and LV dysfunction referred for CMR. We quantified total infarct mass, infarct core mass, and peri-infarct zone normalized for total infarct mass (%PIZ) using signal-intensity criteria of >2SDs, >3SDs, and 2-to-3SDs above remote myocardium, respectively. Mean LVEF was 41±14%. After 3.9 years median follow-up, 66 (22%) patients died (13 SCD; 33 with LVEF>35%). In patients with LVEF >35%, below- median %PIZ carried an annual death rate of 2.8% versus 12% in patients with above- median %PIZ (p<0.001). In a multivariable model, %PIZ maintained strong association with mortality adjusted to patient age, LVEF, RVEF, prolonged QT interval, and total infarct size and resulted in improve risk reclassification 0.492 [95% CI 0.183-0.817]. Conclusions—CMR infarct heterogeneity has a strong association

Journal

Circulation: Cardiovascular ImagingWolters Kluwer Health

Published: Oct 1, 2014

There are no references for this article.